HER-2 Is an Independent Prognostic Factor in Endometrial Cancer: Association With Outcome in a Large Cohort of Surgically Staged Patients
- 20 May 2006
- journal article
- gynecologic cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (15), 2376-2385
- https://doi.org/10.1200/jco.2005.03.4827
Abstract
Purpose To evaluate HER-2 expression and amplification in a large cohort of endometrial cancer with complete surgical staging and outcome data. Patients and Methods A tissue microarray was construc...Keywords
This publication has 20 references indexed in Scilit:
- The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of TherapyThe Oncologist, 2003
- c-erbB-2 in breast cancer: Development of a clinically useful markerSeminars in Oncology, 2002
- neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.Journal of Clinical Oncology, 1998
- Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancerCancer Letters, 1996
- Multivariate survival analysis of clinicopathologic features in surgical stage I endometrioid carcinoma including analysis of HER-2/neu expressionAmerican Journal of Obstetrics and Gynecology, 1995
- HER-2/neu, p53, and DNA Analyses as Prognosticators for Survival in Endometrial CarcinomaPublished by Ovid Technologies (Wolters Kluwer Health) ,1995
- Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancerCancer, 1994
- Expression of EGFR, HER-2/neu, P53, and PCNA in Endometrioid, Serous Papillary, and Clear Cell Endometrial AdenocarcinomasGynecologic Oncology, 1994
- HER-2/neu expression: A major prognostic factor in endometrial cancerGynecologic Oncology, 1992
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989